WEST PHARMACEUTICAL SERVICES, INC. West Pharmaceutical Services, Inc. Share Price Mexican S.E.
Equities
WST *
US9553061055
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,080 MXN | -1.78% |
|
-.--% | -8.25% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 3.01B 53.88B 236B | Sales 2025 * | 3.28B 58.7B 257B | Capitalization | 23.95B 429B 1,876B |
|---|---|---|---|---|---|
| Net income 2024 * | 573M 10.25B 44.89B | Net income 2025 * | 672M 12.03B 52.65B | EV / Sales 2024 * | 7.75 x |
| Net cash position 2024 * | 617M 11.04B 48.32B | Net cash position 2025 * | 1.02B 18.17B 79.53B | EV / Sales 2025 * | 6.99 x |
| P/E ratio 2024 * |
42.6
x | P/E ratio 2025 * |
37
x | Employees | 10,600 |
| Yield 2024 * |
0.28% | Yield 2025 * |
0.34% | Free-Float | 96.38% |
More Fundamentals
* Assessed data
More news
Latest transcript on West Pharmaceutical Services, Inc.
More recommendations
More press releases
More news
| 1 day | -1.78% | ||
| 1 month | +0.60% | ||
| 3 months | +0.60% | ||
| 6 months | -8.25% | ||
| Current year | -8.25% |
1 month
6 066.53
6 190.16
Current year
6 043.956 190.16
1 year
6 043.956 682.31
3 years
5 595.919 649.00
5 years
5 595.919 649.00
10 years
5 595.919 649.00
| Managers | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 55 | 23/04/15 |
Bernard Birkett
DFI | Director of Finance/CFO | 55 | 20/06/18 |
Silji Abraham
CTO | Chief Tech/Sci/R&D Officer | 52 | 25/02/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Douglas Michels
BRD | Director/Board Member | 66 | 31/01/11 |
Eric Green
CEO | Chief Executive Officer | 55 | 23/04/15 |
Paolo Pucci
BRD | Director/Board Member | 63 | 11/09/16 |
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows:
- own manufactured products (81.8%);
- products manufactured under contract (18.2%).
Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
328.7
USD
Average target price
397.1
USD
Spread / Average Target
+20.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.54% | 179B | |
| -0.32% | 108B | |
| -2.05% | 69.03B | |
| -7.14% | 45.83B | |
| +12.24% | 45.39B | |
| +8.60% | 43.17B | |
| +15.37% | 29.89B | |
| +13.65% | 25.49B | |
| -7.05% | 23.27B |
- Stock Market
- Equities
- WST Stock
- WST * Stock